JP2019218397A5 - - Google Patents

Download PDF

Info

Publication number
JP2019218397A5
JP2019218397A5 JP2019160900A JP2019160900A JP2019218397A5 JP 2019218397 A5 JP2019218397 A5 JP 2019218397A5 JP 2019160900 A JP2019160900 A JP 2019160900A JP 2019160900 A JP2019160900 A JP 2019160900A JP 2019218397 A5 JP2019218397 A5 JP 2019218397A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
route
composition according
administered
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019160900A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019218397A (ja
JP6916542B2 (ja
Filing date
Publication date
Priority claimed from JP2017213054A external-priority patent/JP6585139B2/ja
Application filed filed Critical
Publication of JP2019218397A publication Critical patent/JP2019218397A/ja
Publication of JP2019218397A5 publication Critical patent/JP2019218397A5/ja
Priority to JP2021114241A priority Critical patent/JP7427259B2/ja
Application granted granted Critical
Publication of JP6916542B2 publication Critical patent/JP6916542B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019160900A 2012-07-10 2019-09-04 麻酔を誘発する方法 Active JP6916542B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021114241A JP7427259B2 (ja) 2012-07-10 2021-07-09 麻酔を誘発する方法

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261670098P 2012-07-10 2012-07-10
US61/670,098 2012-07-10
US201261681747P 2012-08-10 2012-08-10
US61/681,747 2012-08-10
JP2017213054A JP6585139B2 (ja) 2012-07-10 2017-11-02 麻酔を誘発する方法

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2017213054A Division JP6585139B2 (ja) 2012-07-10 2017-11-02 麻酔を誘発する方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021114241A Division JP7427259B2 (ja) 2012-07-10 2021-07-09 麻酔を誘発する方法

Publications (3)

Publication Number Publication Date
JP2019218397A JP2019218397A (ja) 2019-12-26
JP2019218397A5 true JP2019218397A5 (https=) 2020-02-13
JP6916542B2 JP6916542B2 (ja) 2021-08-11

Family

ID=49914505

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2015521601A Pending JP2015525757A (ja) 2012-07-10 2013-03-14 麻酔を誘発する方法
JP2017213054A Active JP6585139B2 (ja) 2012-07-10 2017-11-02 麻酔を誘発する方法
JP2019160900A Active JP6916542B2 (ja) 2012-07-10 2019-09-04 麻酔を誘発する方法
JP2021114241A Active JP7427259B2 (ja) 2012-07-10 2021-07-09 麻酔を誘発する方法

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2015521601A Pending JP2015525757A (ja) 2012-07-10 2013-03-14 麻酔を誘発する方法
JP2017213054A Active JP6585139B2 (ja) 2012-07-10 2017-11-02 麻酔を誘発する方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021114241A Active JP7427259B2 (ja) 2012-07-10 2021-07-09 麻酔を誘発する方法

Country Status (12)

Country Link
US (7) US20140018414A1 (https=)
EP (3) EP4032533A1 (https=)
JP (4) JP2015525757A (https=)
KR (4) KR20200078684A (https=)
CN (3) CN116585292A (https=)
AU (4) AU2013289204B2 (https=)
BR (1) BR112015000475A2 (https=)
CA (2) CA3135005A1 (https=)
GB (1) GB2507936A (https=)
IL (3) IL301618A (https=)
IN (1) IN2015KN00299A (https=)
WO (2) WO2014011235A1 (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107898791A (zh) 2010-06-03 2018-04-13 药品循环有限责任公司 布鲁顿酪氨酸激酶(btk)抑制剂的应用
CA3135005A1 (en) 2012-07-10 2014-01-16 The Regents Of The University Of California Methods of inducing anesthesia
CN104704129A (zh) 2012-07-24 2015-06-10 药品循环公司 与对布鲁顿酪氨酸激酶(btk)抑制剂的抗性相关的突变
WO2015143400A1 (en) 2014-03-20 2015-09-24 Pharmacyclics, Inc. Phospholipase c gamma 2 and resistance associated mutations
US20160113887A1 (en) * 2014-06-05 2016-04-28 The Regents Of The University Of California Halogenated ether compounds and methods of inducing anesthesia
EP3040061A1 (en) * 2015-01-02 2016-07-06 Fitesa Germany GmbH Nonwoven fabric and process for forming the same
CN105168202A (zh) * 2015-10-09 2015-12-23 烟台毓璜顶医院 一种吸入式复合麻醉维持剂
US10467138B2 (en) * 2015-12-28 2019-11-05 Advanced Micro Devices, Inc. Caching policies for processing units on multiple sockets
US11555024B2 (en) 2018-09-03 2023-01-17 Tosoh Corporation Aldehyde adduct of hexafluoropropylene oxide, method of manufacturing trifluoropyruvyl fluoride dimer and method of manufacturing perfluoro(2,4-dimethyl-2-fluoroformyl-1,3-dioxolane)
JP7307587B2 (ja) * 2018-09-03 2023-07-12 東ソー株式会社 ヘキサフルオロプロピレンオキシドへのアルデヒド類付加体、およびトリフルオロピルビン酸フルオリドダイマーの製造方法
WO2020050249A1 (ja) * 2018-09-03 2020-03-12 東ソ-株式会社 ヘキサフルオロプロピレンオキシドへのアルデヒド類付加体、トリフルオロピルビン酸フルオリドダイマーの製造方法およびパーフルオロ(2,4-ジメチル-2-フルオロホルミル-1,3-ジオキソラン)の製造方法
JP7307586B2 (ja) * 2019-04-26 2023-07-12 東ソー株式会社 パーフルオロ(2,4-ジメチル-2-フルオロホルミル-1,3-ジオキソラン)の製造方法
US11325893B2 (en) * 2018-09-26 2022-05-10 3M Innovative Properties Company Hydrofluoroethers and methods of using same
WO2020123551A1 (en) * 2018-12-10 2020-06-18 Halo Science LLC Stable formulations of anesthetics and associated dosage forms
WO2021146371A1 (en) * 2020-01-17 2021-07-22 Expanesthetics, Inc. Method of inducing analgesia using a halogenated alcohol
WO2022204459A1 (en) * 2021-03-25 2022-09-29 University Of Florida Research Foundation, Inc. Methods and compositions for treatment of low circulating testosterone conditions
US20250340525A1 (en) 2022-12-09 2025-11-06 Expanesthetics, Inc. Fluorinated dioxolane compound
US20240207285A1 (en) * 2022-12-20 2024-06-27 Melt Pharmaceuticals, Inc. Midazolam and ketamine for enhanced sedation
US20250025647A1 (en) * 2023-07-18 2025-01-23 Anecare, Llc Reactivation of and restoration of electrical signaling by neurons involved in controlling brain function
WO2025259445A1 (en) * 2024-06-12 2025-12-18 Expanesthetics, Inc. Method for inducing anesthesia
CN121405558A (zh) * 2024-07-26 2026-01-27 三明市海斯福化工有限责任公司 一种用于冷却剂的氧杂氢氟醚化合物及其制备方法、冷却剂组合物及其应用

Family Cites Families (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1069639B (de) 1959-11-26 Salline Ludwigshalle A.G., Bad Wimpfen Verfahren zur Herstellung von cyclischen Perfluorkohlcnstoffäthern mit 5- oder 6-gliedrigen Ringen
US2594272A (en) 1948-09-10 1952-04-29 Minnesota Mining & Mfg Cyclic fluoroalkylene oxide compounds
GB718318A (en) 1952-06-24 1954-11-10 Minnesota Mining & Mfg Improvements in or relating to process of preparing cyclic fluoroalkylene oxide compounds and the cyclic fluoroalkylene oxide compounds resulting from said process
ES251349A1 (es) 1958-08-21 1960-01-16 Ludwigshalle Saline PROCEDIMIENTO PARA LA OBTENCIoN DE ÉTERES PERFLUOROCARBoNICOS CiCLICOS CON ANILLOS DE 5 o 6 MIEMBROS
US3187748A (en) 1963-04-29 1965-06-08 Merck And Company Inc Inhalation-actuated aerosol device
US3314850A (en) * 1965-09-17 1967-04-18 Allied Chem 2, 2-bis(trifluoromethyl)-1, 3-dioxolane as inhalation anesthetic
US3476860A (en) 1966-12-08 1969-11-04 Air Reduction Halomethyl fluoroisopropyl ethers as anesthetic agents
US3565070A (en) 1969-02-28 1971-02-23 Riker Laboratories Inc Inhalation actuable aerosol dispenser
NL7103057A (https=) 1970-03-12 1971-09-14
US3683092A (en) 1970-07-31 1972-08-08 Baxter Laboratories Inc Method of anesthesia
JPS4812742B1 (https=) 1970-08-17 1973-04-23
JPS4927588B1 (https=) 1970-10-14 1974-07-18
US3749791A (en) * 1971-07-15 1973-07-31 Airco Inc Fluorine or chlorine-substituted 2,2-bis(trifluoromethyl)-1,3-dioxolane anesthetics
NO134730L (https=) 1971-07-19 1900-01-01
US3749793A (en) * 1971-08-02 1973-07-31 Airco Inc Ether compounds as inhalation anesthetics
NL7115893A (https=) 1971-08-09 1973-02-13
NL7115894A (https=) * 1971-08-09 1973-02-13
US3954893A (en) 1971-08-09 1976-05-04 W. R. Grace & Co. New halogenated cyclobutanes
US3870797A (en) 1971-08-09 1975-03-11 Grace W R & Co Anesthetic halogenated cyclobutanes
US3749794A (en) * 1971-08-13 1973-07-31 Airco Inc Ether compounds as inhalation anesthetics
US3897502A (en) 1971-10-22 1975-07-29 Airco Inc Process for making fluorinated ethers
GB1413285A (en) 1971-11-25 1975-11-12 Bespak Industries Ltd Aerosol devices
US4060532A (en) 1972-03-15 1977-11-29 Ici United States Inc. Halogenated dioxolane tranquilizers
GB1448981A (en) 1972-06-09 1976-09-08 Ici Ltd Fluorinated dioxan derivatives
US4017519A (en) 1973-04-05 1977-04-12 Airco, Inc. Fluoro dioxolane anesthetic compounds
US4113435A (en) 1973-07-16 1978-09-12 Massachusetts Institute Of Technology Cryogenically controlled direct fluorination apparatus
JPS514994B2 (https=) 1974-01-31 1976-02-16
DE2520962A1 (de) 1975-05-12 1976-12-02 Hoechst Ag 1.2.2.2-tetrafluoraethyl-fluormethylaether und verfahren zu dessen herstellung
DE2524956A1 (de) 1975-06-05 1976-12-16 Hoechst Ag 2-hydro-perfluor-n-propyl-fluormethylaether und verfahren zu seiner herstellung
DE2604350A1 (de) * 1975-09-22 1977-03-24 Stanford Research Inst Anaesthetisch wirksame halogen-substituierte 2,2-difluor-1,3-dioxolane und verfahren zur inhalations-anaesthesie
JPS5145594B2 (https=) 1975-12-10 1976-12-04
JPS5325552A (en) 1976-08-21 1978-03-09 Agency Of Ind Science & Technol Preparation of perfluorotetrahydrofuran derivatives
JPS53124259A (en) 1977-04-06 1978-10-30 Agency Of Ind Science & Technol Preparation of perfluoro (3-methyltetrahydrofran)
JPS5551084A (en) 1978-10-11 1980-04-14 Agency Of Ind Science & Technol Purification of perfluoro(2-alkyltetrahydropyran)
DE2906447A1 (de) * 1979-02-20 1980-09-04 Hoechst Ag Verfahren zur herstellung von 4,5- perfluor-1,3-dioxolanen und neue verbindungen dieser klasse
US4346246A (en) 1979-03-12 1982-08-24 Airco, Inc. Process for adjusting the halogen content of halogenated aliphatic ethers
US4334105A (en) 1979-04-25 1982-06-08 Airco, Inc. Method for the dehalogenation of ethers
JPS56142877A (en) 1980-07-23 1981-11-07 Agency Of Ind Science & Technol Manufacture of perfluoro (3-methyltetrahydrofuran)
US4533741A (en) 1981-11-19 1985-08-06 E. I. Dupont De Nemours And Company 4,5-Dichloro-2,2,4,5,-tetrafluoro-1,3-dioxolane
US4648393A (en) 1984-11-02 1987-03-10 Ackrad Laboratories, Inc. Breath activated medication spray
US4592348A (en) 1984-12-17 1986-06-03 Waters Iv William C Aerosol inhaler
US4803978A (en) 1985-08-09 1989-02-14 Johnson Iv John J Apparatus for actuating an inhaler
EP0271272B1 (en) 1986-12-01 1992-04-15 Tokuyama Corporation Process for preparation of perfluoro organic compounds
US4762856A (en) 1987-02-02 1988-08-09 Boc, Inc. Anesthetic composition and method of using the same
US4896832A (en) 1987-09-07 1990-01-30 Bespak Plc Dispensing apparatus for metered quantities of pressurised fluid
DE3735467A1 (de) 1987-10-20 1989-05-03 Bayer Ag Verfahren zur herstellung von fluorierten c(pfeil abwaerts)4(pfeil abwaerts)- bis c(pfeil abwaerts)6(pfeil abwaerts)-kohlenwasserstoffen und neue cyclische fluorierte kohlenwasserstoffe, sowie die verwendung von fluorierten c(pfeil abwaerts)4(pfeil abwaerts)- bis c(pfeil abwaerts)6(pfeil abwaerts)-kohlenwasserstoffen als treibgas und arbeitsfluessigkeit fuer waermepumpensysteme
JP2606875B2 (ja) 1988-03-31 1997-05-07 株式会社トクヤマ 有機化合物のフッ素化方法
IT1230873B (it) 1989-06-20 1991-11-08 Ausimont Srl Processo per la preparazione di peraloeteri da peraloolefine e nuovi peraloeteri ottenuti.
US5026801A (en) 1989-09-18 1991-06-25 E. I. Du Pont De Nemours And Company Polyhalodihydrodioxins and polyhalodioxoles
DE69025412T2 (de) 1989-12-11 1996-07-04 Du Pont Teilweise fluorierte verbindungen und polymere
DE4004494A1 (de) 1990-02-14 1991-08-22 Bayer Ag Verfahren zur herstellung von gesaettigten, fluorhaltigen und chlorfreien kohlenwasserstoffen
AU7225891A (en) 1990-03-05 1991-10-10 E.I. Du Pont De Nemours And Company 1,1,2,2,3,3-hexafluorocyclopentane and use thereof in compositions and processes for cleaning
IT1249208B (it) * 1990-06-07 1995-02-20 Ausimont Srl Processo per la preparazione di 1,3-diossolani alogenati e nuovi prodotti ottenuti
IT1244708B (it) 1991-02-07 1994-08-08 Ausimont Spa Processo di dealogenazione di 1,3-diossolani
US5268122A (en) 1991-08-28 1993-12-07 E. I. Du Pont De Nemours And Company Gem-dihydropolyfluoroalkanes and monohydropolyfluoroalkenes, processes for their production, and use of gem-dihydropolyfluoroalkanes in cleaning compositions
US5569796A (en) 1992-09-30 1996-10-29 Nippon Zeon Co., Ltd. Process for producing fluorinated saturated hydrocarbon
US5488189A (en) 1993-12-14 1996-01-30 E. I. Du Pont De Nemours And Company Process for fluorinated propanes and pentanes
IT1269517B (it) 1994-05-19 1997-04-01 Ausimont Spa Polimeri e copolimeri fluorurati contenenti strutture cicliche
JP3818395B2 (ja) 1994-06-30 2006-09-06 独立行政法人産業技術総合研究所 弗素化アルケン誘導体及び弗素化アルカン誘導体の製造方法
JP3729281B2 (ja) 1994-11-24 2005-12-21 独立行政法人産業技術総合研究所 弗素化アルケン誘導体および弗素化アルカン誘導体の製造方法
JPH10316597A (ja) 1997-05-15 1998-12-02 Agency Of Ind Science & Technol 弗素化飽和炭化水素
EP1043297B8 (en) 1997-12-26 2005-09-07 Zeon Corporation Process for the preparation of compounds having -ch2-chf- groups
IT1298257B1 (it) 1998-02-17 1999-12-20 Ausimont Spa Perfluorodiossoli
JP4186253B2 (ja) 1998-03-31 2008-11-26 日本ゼオン株式会社 フッ素化飽和炭化水素の製造方法
JP4120043B2 (ja) 1998-04-01 2008-07-16 日本ゼオン株式会社 フッ素化不飽和炭化水素の製造方法
JP3072083B2 (ja) 1998-11-04 2000-07-31 財団法人地球環境産業技術研究機構 含フッ素ジオキソランおよびその製造方法
US6218586B1 (en) 1998-11-05 2001-04-17 Central Glass Company, Limited Method for preparing perhalogenated five-membered cyclic compound
JP3856076B2 (ja) 1998-11-30 2006-12-13 日本ゼオン株式会社 ヘプタフルオロシクロペンタンの製造方法
JP3794859B2 (ja) 1999-03-01 2006-07-12 セントラル硝子株式会社 パーハロゲン化シクロペンタンの製造方法
JP4423414B2 (ja) 2000-02-29 2010-03-03 独立行政法人産業技術総合研究所 ヘプタフルオロシクロペンタンの製造方法
JP2001240569A (ja) 2000-02-29 2001-09-04 Nippon Zeon Co Ltd −ch2−chf−基を有する化合物の製造方法
JP4306081B2 (ja) 2000-03-07 2009-07-29 日本ゼオン株式会社 1,1,2,2,3,3,4−ヘプタフルオロシクロペンタンの製造方法およびその製造装置
JP3897081B2 (ja) 2000-03-17 2007-03-22 日本ゼオン株式会社 1−クロロヘプタフルオロシクロペンテンの製造方法
JP4169121B2 (ja) 2001-02-13 2008-10-22 日本ゼオン株式会社 ヘプタフルオロシクロペンタンの製造方法
PL206780B1 (pl) 2001-10-17 2010-09-30 Minrad Inc Układ do podawania gazu pacjentowi
ITMI20030606A1 (it) 2003-03-27 2004-09-28 Solvay Solexis Spa Procedimento per preparare idrofluoroeteri.
US7067468B2 (en) 2003-06-20 2006-06-27 Degroot Richard J Azeotrope compositions containing a fluorocyclopentane
ITMI20071481A1 (it) 2007-07-23 2009-01-24 Milano Politecnico Processo per la sintesi di perfluoroalchileteri
EP2195031A1 (en) 2007-08-27 2010-06-16 Wyeth a Corporation of the State of Delaware Compositions and methods employing nmda antagonists for achieving an anesthetic-sparing effect
US20120219596A1 (en) 2009-07-30 2012-08-30 Wendelin Stark Injectable formulation for treatment and protection of patients having an inflammatory reaction or an ischemia-reperfusion event
CN101698649B (zh) * 2009-10-22 2012-03-07 李世系 一种用于麻醉的短效催眠镇静的化合物
CA3135005A1 (en) 2012-07-10 2014-01-16 The Regents Of The University Of California Methods of inducing anesthesia
US20160113887A1 (en) 2014-06-05 2016-04-28 The Regents Of The University Of California Halogenated ether compounds and methods of inducing anesthesia

Similar Documents

Publication Publication Date Title
JP2019218397A5 (https=)
Lee et al. Comparison between dexmedetomidine and remifentanil for controlled hypotension and recovery in endoscopic sinus surgery
WO2009009501A4 (en) Non-basic melanin concentrating hormone receptor-1 antagonists and methods
JP2005527496A5 (https=)
JP2006510618A5 (https=)
JP2008501705A5 (https=)
JP2024173998A5 (https=)
JP2008539268A5 (https=)
Chen et al. Safety and tolerability of esketamine in propofol based sedation for endoscopic variceal ligation with or without injection sclerotherapy: randomized controlled trial
JP2019520344A5 (https=)
EP3474853A1 (en) Liponucleotide-based therapy for ards
JP7592007B2 (ja) 睡眠時無呼吸の治療のためのα2‐アドレナリン受容体サブタイプC (ALPHA‐2C)拮抗薬
RU2002101622A (ru) Нафтохиноновые производные и их использование для лечения и борьбы с туберкулезом
JP2005508363A5 (https=)
Kapala et al. Neuraxial anesthesia and intraoperative bilevel positive airway pressure in a patient with severe chronic obstructive pulmonary disease and obstructive sleep apnea undergoing elective sigmoid resection
JPWO2022072520A5 (https=)
RU2008108175A (ru) Комбинация соединений, которые можно использовать при лечении респираторных заболеваний, особенно хронической оструктивной болезни легких (copo) и астмы
JPWO2023069880A5 (https=)
RU2013118026A (ru) Карбонатные производные для лечения кашля
Ubale Anesthetic considerations in functional endoscopic sinus surgery
Muniyappa et al. Effect of dexmedetomidine bolus dose on isoflurane consumption in surgical patients under general anesthesia
Shono et al. Disappearance of wheezing during epidural lidocaine anesthesia in a patient with bronchial asthma
EA023648B1 (ru) ИНДАНИЛЗАМЕЩЕННЫЕ 4,5,6,7-ТЕТРАГИДРО-1H-ПИРАЗОЛО[4,3-с]ПИРИДИНЫ, ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ ЛЕКАРСТВЕННОГО СРЕДСТВА И СОДЕРЖАЩИЕ ИХ ФАРМАЦЕВТИЧЕСКИЕ ПРЕПАРАТЫ
CN1137686C (zh) 椎管狭窄的治疗药
Lađević et al. Combined general end epidural anesthesia versus general anesthesia for radical cystectomy